(2021). Correction: Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer. BMJ Publishing Group.
Chicago Style (17th ed.) CitationCorrection: Quantitative Systems Pharmacology Model Predictions for Efficacy of Atezolizumab and Nab-paclitaxel in Triple-negative Breast Cancer. BMJ Publishing Group, 2021.
MLA (8th ed.) CitationCorrection: Quantitative Systems Pharmacology Model Predictions for Efficacy of Atezolizumab and Nab-paclitaxel in Triple-negative Breast Cancer. BMJ Publishing Group, 2021.
Warning: These citations may not always be 100% accurate.